Press Releases
February 8, 2008 Solstice Neurosciences, Inc. Issues a Corporate Response to FDA Early Communication December 21, 2007 Dennis L. Smith appointed President and Chief Executive Officer of Solstice Neurosciences, Inc. December 13, 2007 Solstice Neurosciences, Inc. launches MYOBLOC™ University. October 11, 2007 Dennis Smith appointed Executive Chairman to Board of Directors of Solstice Neurosciences, Inc. June 6, 2007 Solstice Neurosciences Presents Escalating Dose Study at International Congress in Istanbul, Turkey June 5, 2007 Solstice Neurosciences, Inc.’s President & CEO, Shawn Patrick O’Brien Named Ernst & Young Entrepreneur Of The Year 2007 Award Finalist In Greater Philadelphia May 15, 2007 Solstice Neurosciences, Inc. Announces Commercialization Agreement November 8, 2006 Solstice Neurosciences Raises $85 Million in Private Financing September 18, 2006 Solstice Neurosciences Sponsors 'Universal Pain' Exhibit at International Museum of Surgical Sciences in Chicago, Illinois
July 5, 2006 Exclusive licensing agreement reached between Solstice Neurosciences, Inc. and DreamPharma Corporation for cosmetic and therapeutic uses of Myobloc® and Neurobloc® in Korea
June 15, 2006 Myobloc®(Botulinum Toxin Type B) gains expanded access in First Coast Service Options' Florida and Connecticut Medicare Program
May 1, 2006 Noridian Part B Carrier grants a single coverage policy for MYOBLOC Botulinum Toxin Type B and Botulinum Toxin Type A
April 10, 2006 Newly released data on Myobloc reports the first prospective botulinum toxin study of long-term effectiveness and safety in patients treated for up to 4 years
April 5, 2006 Solstice Neurosciences, Inc. releases new data confirming effectiveness of Myobloc as a first line therapy
June 21, 2005 Head-to-Head Trial Shows that Myobloc NeuroBloc Clinically Equivalent to Botoxin Cervical Dystonia
Other News
March 13, 2007 Solstice Neurosciences, Inc. Profiled on Pennsylvania Bio Website October 2006 Movement Disorder Awareness Month
June 4-11 , 2006 National Dystonia Awareness Week.
February 22, 2006 Solstice Neurosciences, Inc. plans to exhibit at the BIO 2006 International Convention.
February 15, 2006 Pennsylvania Adds Myobloc® to Medicare Coverage.
December 12, 2005 Solstice Neurosciences, Inc. Announces a New Global Headquarters.
August 3, 2005 New States Added to Myobloc® Medicare Coverage.
Please visit our "Upcoming Events" page for more info.
